Baxter, Mark


  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Graduated from the University of Cambridge in 2012 including an intercalated degree in Pharmacology (1st). He then undertook a Respiratroy Academic Foundation Job affiliated with the University of East Anglia and NHS Norfolk and Norwich. During these 2 years he obtained his MRCP(UK).

Following his Foundation Years, Mark worked for a year in Canberra, Australia. He obtained registration with the Australian Medical Council and retains registration. He returned to Scotland to undertake Core Medical Training, including a rotation at the Beatson West of Scotland Cancer Centre.

He began Specialty training in Medical Oncology in 2017 before taking up a SCREDS Clinical Lectureship with Prof Petty at the University of Dundee. He obtained CSO funding to undertake a 3 year PhD focussed on frailty in advanced gastroesophageal cancer and began this in August 2020. 


CSO Clinical Academic Fellow

Vice chairman of NOTCH (National Oncology Trainee Collaborative for Healthcare Research)

Research interests

Frailty in advanced cancer

Biomarkers for chemosensitivity

Supportive care

Quality of life

Education/Academic qualification


Award Date: 1 May 2018

Doctor of Medicine, University of Cambridge

Award Date: 27 Jun 2012

Bachelor of Arts, University of Cambridge

1 Oct 200630 Jun 2009

Award Date: 30 Jun 2009

External positions

Medical Oncology Registrar, NHS Tayside

10 Sep 2018 → …


  • RC0254 Neoplasms. Tumors. Oncology (including Cancer)
  • Frailty
  • Geriatric Oncology
  • Toxicity
  • Gastric cancer
  • Oesophageal cancer


Dive into the research topics where Mark Baxter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 6 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.